株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

インドのワクチン市場の分析と予測:2015年〜2019年

Indian Vaccine Market Report and Forecast 2015-2019

発行 IMARC Services Pvt. Ltd. 商品コード 345917
出版日 ページ情報 英文 102 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
インドのワクチン市場の分析と予測:2015年〜2019年 Indian Vaccine Market Report and Forecast 2015-2019
出版日: 2015年11月19日 ページ情報: 英文 102 Pages
概要

インド経済の持続的成長によって、公的・民間の医療費は必然的に上昇し、成人向けワクチン市場は、今後数年間は、CAGRで15%以上の目覚ましい成長が予測されています。

当レポートでは、インドのワクチン市場について調査分析し、ワクチンの概要と疫学、市場動向 (現在・過去) 、セグメント別の市場分析、市場の見通しなど、体系的な情報を提供しています。

第1章 調査手法と市場定義

第2章 エグゼクティブサマリー

第3章 インドのワクチン市場

  • イントロダクションと歴史
  • 市場動向 (現在・過去)
  • 市場内訳:セグメント別
  • 市場内訳:主要企業別
  • 市場促進要因と課題
  • 市場の見通し

第4章 単味ワクチンと混合ワクチンの市場分析

  • BCG
  • HIB
  • インフルエンザ
  • 水痘
  • 腸チフス
  • 日本脳炎
  • 麻疹
  • 破傷風トキソイド
  • A型肝炎
  • 風疹
  • DPT
  • ポリオ
  • MMR
  • ロタウイルス
  • B型肝炎
  • 肺炎球菌
  • 髄膜炎菌
  • 狂犬病
  • HPV

第5章 規制の枠組み

図表

目次
Product Code: SRP071533

The market for vaccines in India shows immense potential. The country has not only been self-sufficient in meeting its domestic requirements but has also emerged as a leading global exporter of vaccines across the world. The Indian vaccine industry began as a network of state owned manufacturers supplying basic childhood vaccines to the national immunization programme. In recent decades, however, a number of privately owned firms have emerged which have completely transformed the industry landscape.Their biggest success factor is similar to the approach that has been followed by Indian generic pharmaceutical manufacturers. This modelinvolved concerted efforts to develop vaccines for not only tropical neglected diseases, but also cheaper alternatives of vaccines that are already available in the West.

Despite its recent growth, however, the Indian vaccine industry still has a number of challenges to address. The market remains small (currently accounts for less than 2% of the global market) and underpenetrated compared to the developed countries. The country also lags behind its global peers in terms of vaccine coverage with a significant number of lives lost due to vaccine preventable deaths.Nevertheless, despite these challenges the situation appears bright for vaccine manufacturers. The country has around 25-30 Million births each year. This coupled with the sustained growth of the Indian economy, a consequent rise in public and private healthcare expenditures and a strong growth in the market for adult vaccines is expected to propel the Indian vaccine market to grow at a CAGR of over 15% during the coming years.

IMARC's new report entitled "Indian Vaccine Market Report and Forecast 2015-2019" provides an analytical and statistical insight into the Indian vaccine market.The study is an outcome of an intensive research on the Indian vaccine industry and draws upon a comprehensive analysis of every major vaccine in India. The report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Indian vaccine market in any form.

Key Vaccines Covered in the Report

BCG, HIB, Influenza, Varicella, Typhoid, Japanese Encephalitis, Measles, Tetanus Toxoid, Hepatitis A, Rubella, DPT, Polio, MMR, Rotavirus, Hepatitis B, Pneumococcal, Meningococcal, Rabies, HPV

Focus of the Analysis for Each Vaccine

  • Vaccine Overview and Epidemiology
  • Historical and Current Market Trends
  • Market Breakup by Prescriber
  • Market Breakup by Public and Private Sector
  • Market Outlook

Table of Contents

1. Research Methodology and Market Definitions

2. Executive Summary

3. Indian Vaccine Market

  • 3.1 Introduction and History
  • 3.2 Current and Historical Market Trends
  • 3.3 Market Breakup by Segment
  • 3.4 Market Breakup by Key Players
  • 3.5 Market Drivers and Challenges
  • 3.6 Market Outlook

4. Market Analysis of Various Monovalent and Combined Vaccines

  • 4.1 BCG Vaccine Market
    • 4.1.1 Vaccine Overview and Epidemiology
    • 4.1.2 Historical and Current Market Trends
    • 4.1.3 Market Breakup by Prescriber
    • 4.1.4 Market Breakup by Public and Private Sectors
    • 4.1.5 Market Outlook
  • 4.2 HIB Vaccine Market
    • 4.2.1 Vaccine Overview and Epidemiology
    • 4.2.2 Historical and Current Market Trends
    • 4.2.3 Market Breakup by Prescriber
    • 4.2.4 Market Breakup by Public and Private Sectors
    • 4.2.5 Market Outlook
  • 4.3 Influenza Vaccine Market
    • 4.3.1 Vaccine Overview and Epidemiology
    • 4.3.2 Historical and Current Market Trends
    • 4.3.3 Market Breakup by Prescriber
    • 4.3.4 Market Breakup by Public and Private Sectors
    • 4.3.5 Market Outlook
  • 4.4 Varicella Vaccine Market
    • 4.4.1 Vaccine Overview and Epidemiology
    • 4.4.2 Historical and Current Market Trends
    • 4.4.3 Market Breakup by Prescriber
    • 4.4.4 Market Breakup by Public and Private Sectors
    • 4.4.5 Market Outlook
  • 4.5 Typhoid Vaccine Market
    • 4.5.1 Vaccine Overview and Epidemiology
    • 4.5.2 Historical and Current Market Trends
    • 4.5.3 Market Breakup by Prescriber
    • 4.5.4 Market Breakup by Public and Private Sectors
    • 4.5.5 Market Outlook
  • 4.6 Japanese Encephalitis Vaccine Market
    • 4.6.1 Vaccine Overview and Epidemiology
    • 4.6.2 Historical and Current Market Trends
    • 4.6.3 Market Breakup by Prescriber
    • 4.6.4 Market Breakup by Public and Private Sectors
    • 4.6.5 Market Outlook
  • 4.7 Measles Vaccine Market
    • 4.7.1 Vaccine Overview and Epidemiology
    • 4.7.2 Historical and Current Market Trends
    • 4.7.3 Market Breakup by Prescriber
    • 4.7.4 Market Breakup by Public and Private Sectors
    • 4.7.5 Market Outlook
  • 4.8 Tetanus Toxoid Vaccine Market
    • 4.8.1 Vaccine Overview and Epidemiology
    • 4.8.2 Historical and Current Market Trends
    • 4.8.3 Market Breakup by Prescriber
    • 4.8.4 Market Breakup by Public and Private Sectors
    • 4.8.5 Market Outlook
  • 4.9 Hepatitis A Vaccine Market
    • 4.9.1 Vaccine Overview and Epidemiology
    • 4.9.2 Historical and Current Market Trends
    • 4.9.3 Market Breakup by Prescriber
    • 4.9.4 Market Breakup by Public and Private Sectors
    • 4.9.5 Market Outlook
  • 4.10 Rubella Vaccine Market
    • 4.10.1 Vaccine Overview and Epidemiology
    • 4.10.2 Historical and Current Market Trends
    • 4.10.3 Market Breakup by Prescriber
    • 4.10.4 Market Breakup by Public and Private Sectors
    • 4.10.5 Market Outlook
  • 4.11 DPT Vaccine Market
    • 4.11.1 Vaccine Overview and Epidemiology
    • 4.11.2 Historical and Current Market Trends
    • 4.11.3 Market Breakup by Prescriber
    • 4.11.4 Market Breakup by Public and Private Sectors
    • 4.11.5 Market Outlook
  • 4.12 Polio Vaccine Market
    • 4.12.1 Vaccine Overview and Epidemiology
    • 4.12.2 Historical and Current Market Trends
    • 4.12.3 Market Breakup by Prescriber
    • 4.12.4 Market Breakup by Public and Private Sectors
    • 4.12.5 Market Outlook
  • 4.13 MMR Vaccine Market
    • 4.13.1 Vaccine Overview and Epidemiology
    • 4.13.2 Historical and Current Market Trends
    • 4.13.3 Market Breakup by Prescriber
    • 4.13.4 Market Breakup by Public and Private Sectors
    • 4.13.5 Market Outlook
  • 4.14 Rotavirus Vaccine Market
    • 4.14.1 Vaccine Overview and Epidemiology
    • 4.14.2 Historical and Current Market Trends
    • 4.14.3 Market Breakup by Prescriber
    • 4.14.4 Market Breakup by Public and Private Sectors
    • 4.14.5 Market Outlook
  • 4.15 Hepatitis B Vaccine Market
    • 4.15.1 Vaccine Overview and Epidemiology
    • 4.15.2 Historical and Current Market Trends
    • 4.15.3 Market Breakup by Prescriber
    • 4.15.4 Market Breakup by Public and Private Sectors
    • 4.15.5 Market Outlook
  • 4.16 Pneumococcal Vaccine Market
    • 4.16.1 Vaccine Overview and Epidemiology
    • 4.16.2 Historical and Current Market Trends
    • 4.16.3 Market Breakup by Prescriber
    • 4.16.4 Market Breakup by Public and Private Sectors
    • 4.16.5 Market Outlook
  • 4.17 Meningococcal Vaccine Market
    • 4.17.1 Vaccine Overview and Epidemiology
    • 4.17.2 Historical and Current Market Trends
    • 4.17.3 Market Breakup by Prescriber
    • 4.17.4 Market Breakup by Public and Private Sectors
    • 4.17.5 Market Outlook
  • 4.18 Rabies Vaccine Market
    • 4.18.1 Vaccine Overview and Epidemiology
    • 4.18.2 Historical and Current Market Trends
    • 4.18.3 Market Breakup by Prescriber
    • 4.18.4 Market Breakup by Public and Private Sectors
    • 4.18.5 Market Outlook
  • 4.19 HPV Vaccine Market
    • 4.19.1 Vaccine Overview and Epidemiology
    • 4.19.2 Historical and Current Market Trends
    • 4.19.3 Market Breakup by Prescriber
    • 4.19.4 Market Breakup by Public and Private Sectors
    • 4.19.5 Market Outlook

5. Regulatory Framework

List of Figures

  • Figure 1: Vaccine Development and Introduction in Indian Vaccine Market
  • Figure 2: Comparison of Global Vaccine Market and Indian Vaccine Market
  • Figure 3: India: Vaccine Market: Sales Value (in Billion INR), 2007 - 2014
  • Figure 4: India: Vaccine Market: Healthcare and Immunization Budget (In Billion INR), 2007 - 2014
  • Figure 5: India: Vaccine Market: Standard Procedure of Introducing New Vaccine
  • Figure 6: India: Vaccine Market: Spending by Different Organizations on Polio Program
  • Figure 7: India: Vaccine Market: Vaccine Coverage in Uttar Pradesh and Tamil Nadu
  • Figure 8: India: Vaccine Market: Value Breakup by Therapies (in %), 2014
  • Figure 9: India: Monovalent Vaccine Market: Value Breakup by Vaccine (in %), 2014
  • Figure 10: India: Combined Vaccine Market: Value Breakup by Vaccine (in %), 2014
  • Figure 11: India: Vaccine Market: Value Breakup by Key Players (in %), 2014
  • Figure 12: India: BCG Vaccine Market: Sales Value (in Million INR), 2007 - 2014
  • Figure 13: India: BCG Vaccine Market: Doses Administered (in Million), 2007 - 2014
  • Figure 14: India: BCG Vaccine Market: Breakup by Prescriber (in %), 2014
  • Figure 15: India: BCG Vaccine Market: Breakup by Sector (in %), 2014
  • Figure 16: India: BCG Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
  • Figure 17: India: BCG Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
  • Figure 18: India: HIB Vaccine Market: Sales Value (in Million INR), 2007 - 2014
  • Figure 19: India: HIB Vaccine Market: Doses Administered (in '000), 2007 - 2014
  • Figure 20: India: HIB Vaccine Market: Breakup by Prescriber (in %), 2014
  • Figure 21: India: HIB Vaccine Market: Breakup by Sector (in %), 2014
  • Figure 22: India: HIB Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
  • Figure 23: India: HIB Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
  • Figure 24: India: Influenza Vaccine Market: Sales value (in Million INR), 2010 - 2014
  • Figure 25: India: Influenza Vaccine Market: Doses Administered (in Million), 2010 - 2014
  • Figure 26: India: Influenza Vaccine Market: Breakup by Prescriber (in %), 2014
  • Figure 27: India: Influenza Vaccine Market: Breakup by Sector (in %), 2014
  • Figure 28: India: Influenza Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
  • Figure 29: India: Influenza Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
  • Figure 30: India: Varicella Vaccine Market: Sales Value (in Million INR), 2007 - 2014
  • Figure 31: India: Varicella Vaccine Market: Doses Administered (in Million), 2007 - 2014
  • Figure 32: India: Varicella Vaccine Market: Breakup by Prescriber (in %), 2014
  • Figure 33: India: Varicella Vaccine Market: Breakup by Sector (in %), 2014
  • Figure 34: India: Varicella Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
  • Figure 35: India: Varicella Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
  • Figure 36: India: Typhoid Vaccine Market: Sales value (in Million INR), 2007 - 2014
  • Figure 37: India: Typhoid Vaccine Market: Doses Administered (in Million), 2007 - 2014
  • Figure 38: India: Typhoid Vaccine Market: Breakup by Prescriber (in %), 2014
  • Figure 39: India: Typhoid Vaccine Market: Breakup by Sector (in %), 2014
  • Figure 40: India: Typhoid Vaccine Market: Sales Value Forecast (in Millions INR), 2015 - 2019
  • Figure 41: India: Typhoid Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
  • Figure 42: India: JE Vaccine Market: Sales Value (in Million INR), 2007 - 2014
  • Figure 43: India: JE Vaccine Market: Doses Administered (in Million), 2007 - 2014
  • Figure 44: India: JE Vaccine Market: Breakup by Prescriber (in %), 2014
  • Figure 45: India: JE Vaccine Market: Breakup by Sector (in %), 2014
  • Figure 46: India: JE Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
  • Figure 47: India: JE Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
  • Figure 48: India: Measles Vaccine Market: Sales Value (in Million INR), 2007 - 2014
  • Figure 49: India: Measles Vaccine Market: Doses Administered (in Million), 2007 - 2014
  • Figure 50: India: Measles Vaccine Market: Breakup by Prescriber (in %), 2014
  • Figure 51: India: Measles Vaccine Market: Breakup by Sector (in %), 2014
  • Figure 52: India: Measles Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
  • Figure 53: India: Measles Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
  • Figure 54: India: TT Vaccine Market: Sales Value (in Million INR), 2007 - 2014
  • Figure 55: India: TT Vaccine Market: Doses Administered (in Million), 2007 - 2014
  • Figure 56: India: TT Vaccine Market: Breakup by Prescriber (in %), 2014
  • Figure 57: India: TT Vaccine Market: Breakup by Sector (in %), 2014
  • Figure 58: India: TT Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
  • Figure 59: India: TT Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
  • Figure 60: India: Hepatitis A Vaccine Market: Sales Value (in Million INR), 2007 - 2014
  • Figure 61: India: Hepatitis A Vaccine Market: Doses Administered (in Million), 2007 - 2014
  • Figure 62: India: Hepatitis A Vaccine Market: Breakup by Prescriber (in %), 2014
  • Figure 63: India: Hepatitis A Vaccine Market: Breakup by Sector (in %), 2014
  • Figure 64: India: Hepatitis A Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
  • Figure 65: India: Hepatitis A Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
  • Figure 66: India: Rubella Vaccine Market: Sales Value (in Million INR), 2007 - 2014
  • Figure 67: India: Rubella Vaccine Market: Doses Administered (in Million), 2007 - 2014
  • Figure 68: India: Rubella Vaccine Market: Breakup by Prescriber (in %), 2014
  • Figure 69: India: Rubella Vaccine Market: Breakup by Sector (in %), 2014
  • Figure 70: India: Rubella Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
  • Figure 71: India: Rubella Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
  • Figure 72: India: DPT Vaccine Market: Sales Value (in Million INR), 2007 - 2014
  • Figure 73: India: DPT Vaccine Market: Doses Administered (in Million), 2007 - 2014
  • Figure 74: India: DPT Vaccine Market: Breakup by Prescriber (in %), 2014
  • Figure 75: India: DPT Vaccine Market: Breakup by Sector (in %), 2014
  • Figure 76: India: DPT Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
  • Figure 77: India: DPT Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
  • Figure 78: India: Polio Vaccine: Incidence of Polio, 2007 - 2014
  • Figure 79: India: Polio Vaccine Market: Sales Value (in Million INR), 2007 - 2014
  • Figure 80: India: Polio Vaccine Market: Doses Administered (in Million), 2007 - 2014
  • Figure 81: India: Polio Vaccine Market: Breakup by Prescriber (in %), 2014
  • Figure 82: India: Polio Vaccine Market: Breakup by Sector (in %), 2014
  • Figure 83: India: Polio Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
  • Figure 84: India: Polio Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
  • Figure 85: India: MMR Vaccine Market: Sales Value (in Million INR), 2007 - 2014
  • Figure 86: India: MMR Vaccine Market: Doses Administered (in Million), 2007 - 2014
  • Figure 87: India: MMR Vaccine Market: Breakup by Prescriber (in %), 2014
  • Figure 88: India: MMR Vaccine Market: Breakup by Sector (in %), 2014
  • Figure 89: India: MMR Vaccine Market: Sales Value Forecast (in INR Million), 2015 - 2019
  • Figure 90: India: MMR Vaccine Market: Doses Administered Forecast (In Million), 2015 - 2019
  • Figure 91: India: Rotavirus Vaccine Market: Sales Value (in Million INR), 2010-2014
  • Figure 92: India: Rotavirus Vaccine Market: Doses Administered (in Million), 2010-2014
  • Figure 93: India: Rotavirus Vaccine Market: Breakup by Prescriber (In %), 2014
  • Figure 94: India: Rotavirus Vaccine Market: Breakup by Sector (in %), 2014
  • Figure 95: India: Rotavirus Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
  • Figure 96: India: Rotavirus Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
  • Figure 97: India: Hepatitis B Vaccine Market: Sales Value (in Million INR), 2007 - 2014
  • Figure 98: India: Hepatitis B Vaccine Market: Doses Administered (in Million), 2007 - 2014
  • Figure 99: India: Hepatitis B Vaccine Market: Breakup by Prescriber (in %), 2014
  • Figure 100: India: Hepatitis B Vaccine Market: Breakup by Sector (in %), 2014
  • Figure 101: India: Hepatitis B Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
  • Figure 102: India: Hepatitis B Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
  • Figure 103: India: Pneumonia Vaccine Market: Sales Value (in Million INR), 2007 - 2014
  • Figure 104: India: Pneumonia Vaccine Market: Doses Administered (in Million), 2007 - 2014
  • Figure 105: India: Pneumonia Vaccine Market: Breakup by Prescriber (in %), 2014
  • Figure 106: India: Pneumonia Vaccine Market: Breakup by Sector (in %), 2014
  • Figure 107: India: Pneumonia Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
  • Figure 108: India: Pneumonia Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
  • Figure 109: India: Meningococcal Vaccine Market: Sales Value (in Million INR), 2007 - 2014
  • Figure 110: India: Meningococcal Vaccine Market: Doses Administered (in Million), 2007 - 2014
  • Figure 111: India: Polio Vaccine Market: Breakup by Prescriber (in %), 2014
  • Figure 112: India: Polio Vaccine Market: Breakup by Sector (in %), 2014
  • Figure 113: India: Meningococcal Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
  • Figure 114: India: Meningococcal Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
  • Figure 115: India: Rabies Vaccine Market: Sales Value (in Million INR), 2007 - 2014
  • Figure 116: India: Rabies Vaccine Market: Doses Administered (in Million), 2007 - 2014
  • Figure 117: India: Polio Vaccine Market: Breakup by Prescriber (in %), 2014
  • Figure 118: India: Polio Vaccine Market: Breakup by Sector (in %), 2014
  • Figure 119: India: Rabies Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
  • Figure 120: India: Rabies Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
  • Figure 121: India: HPV Vaccine Market: Sales Value (in Million INR), 2007 - 2014
  • Figure 122: India: HPV Vaccine Market: Doses Administered (in Million), 2007 - 2014
  • Figure 123: India: HPV Vaccine Market: Breakup by Prescriber (in %), 2014
  • Figure 124: India: HPV Vaccine Market: Breakup by Sector (in %), 2014
  • Figure 125: India: HPV Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
  • Figure 126: India: HPV Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019

List of Tables

  • Table 1: India: Vaccine Market Overview
  • Table 2: India: Monovalent Vaccine Market: Value Breakup by Vaccine, 2014 and 2019
  • Table 3: India: Combined Vaccine Market: Value Breakup by Vaccine, 2014 and 2019
  • Table 4: India: Vaccine Market: Structural Barriers
  • Table 5: India: BCG Vaccine: Overview
  • Table 6: India: BCG Vaccine: Incidence of TB, 2013
  • Table 7: India: HIB Vaccine: Overview
  • Table 8: India: HIB Vaccine: Incidence of HIB, 2006 and 2013
  • Table 9: India: Influenza Vaccine: Overview
  • Table 10: India: Influenza Vaccine: Incidence of Influenza, 2011 and 2013
  • Table 11: India: Varicella Vaccine: Overview
  • Table 12: India: Varicella Vaccine: Incidence of Chickenpox, 2013
  • Table 13: India: Typhoid Vaccine: Overview
  • Table 14: India: Typhoid Vaccine: Incidence of Typhoid, 2013
  • Table 15: India: JE Vaccine: Overview
  • Table 16: India: JE Vaccine: Incidence of JE, 2012 and 2013
  • Table 17: India: Measles Vaccine: Overview
  • Table 18: India: Measles Vaccine: Incidence, 2007 - 2013
  • Table 19: India: Tetanus Toxoid Vaccine: Overview
  • Table 20: India: Tetanus Toxoid Vaccine: Incidence of Tetanus Toxoid, 2007 - 2013
  • Table 21: India: Hepatitis A Vaccine: Overview
  • Table 22: India: Hepatitis A Vaccine: Incidence of Hepatitis A, 2012 and 2013
  • Table 23: India: Rubella Vaccine: Overview
  • Table 24: India: Rubella Vaccine: Incidence of Rubella
  • Table 25: India: DPT Vaccine: Overview
  • Table 26: India: DPT Vaccine: Incidence of DPT, 2007 - 2013
  • Table 27: India: Polio Vaccine: Overview
  • Table 28: India: MMR Vaccine: Overview
  • Table 29: India: MMR Vaccine: Incidence of Measles, Mumps & Rubella, 2011 and 2013
  • Table 30: India: Rotavirus Vaccine: Overview
  • Table 31: India: Rotavirus Vaccine: Incidence of Rotavirus, 2013
  • Table 32: India: Hepatitis B Vaccine: Overview
  • Table 33: India: Hepatitis B Vaccine: Incidence of Hepatitis B, 2011 and 2014
  • Table 34: India: Pneumonia Vaccine: Overview
  • Table 35: India: Pneumonia Vaccine: Incidence of Pneumonia, 2012 and 2013
  • Table 36: India: Meningococcal Vaccine: Overview
  • Table 37: India: Meningococcal Vaccine: Incidence of Meningococcal, 2007 and 2013
  • Table 38: India: Rabies Vaccine: Overview
  • Table 39: India: Rabies Vaccine: Incidence of Rabies, 2013
  • Table 40: India: HPV Vaccine: Overview
  • Table 41: India: HPV Vaccine: Incidence of HPV, 2007 and 2014
Back to Top